4

NCT00745901 – An Open Label Study to Evaluate Cycle Control with Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) and Yaz (drospirenone/ethinyl estradiol) in Healthy Sexually Active Females

Posted on January 23, 2018 by tsuperadmin -

NCT01394991 – A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia

Posted on January 23, 2018 by tsuperadmin -

NCT02025907 – A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy

Posted on October 26, 2017 by tsuperadmin -

NCT00378092 – A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia

Posted on September 16, 2015 by tsuperadmin -

NCT00799487 – Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral and Cognitive Effects of CONCERTA on Older Children With ADHD (The ABC Study)

Posted on February 10, 2015 by tsuperadmin -

NCT00799409 – The ABC Study: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study Evaluating the Academic, Behavioral, and Cognitive Effects of CONCERTA on Older Children With ADHD

Posted on February 10, 2015 by tsuperadmin -

NCT00212810 – TOPAMAX (Topiramate) Intervention to Prevent Transformation of Episodic Migraine: The Topiramate INTREPID Study

Posted on November 10, 2014 by tsuperadmin -

NCT00866996 – A Multi-center Randomized Parallel Group Study Evaluating Treatment Outcomes of Concerta (Extended Release Methylphenidate) and Strattera (Atomoxetine) in Children With Attention-deficit/Hyperactivity Disorder

Posted on October 20, 2014 by tsuperadmin -